These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia. Juhl D, Eichler P, Lubenow N, Strobel U, Wessel A, Greinacher A. Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367 [Abstract] [Full Text] [Related]
28. Heparin-induced thrombocytopenia: recent experience in a large teaching hospital. Sturtevant JM, Pillans PI, Mackenzie F, Gibbs HH. Intern Med J; 2006 Jul; 36(7):431-6. PubMed ID: 16780449 [Abstract] [Full Text] [Related]
29. Incidence of heparin-PF4 complex antibody formation and heparin-induced thrombocytopenia in acute coronary syndrome. Matsuo T, Tomaru T, Kario K, Hirokawa T, HIT Research Group of Japan. Thromb Res; 2005 Jul; 115(6):475-81. PubMed ID: 15792678 [Abstract] [Full Text] [Related]
37. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia. Levy JH, Tanaka KA, Hursting MJ. Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208 [Abstract] [Full Text] [Related]
39. P-selectin and antibodies against heparin-platelet factor 4 in patients with venous or arterial diseases after a 7-day heparin treatment. Papalambros E, Sigala F, Travlou A, Bastounis E, Mirilas P. J Am Coll Surg; 2004 Jul; 199(1):69-77. PubMed ID: 15217633 [Abstract] [Full Text] [Related]